| GlaxoSmithKline Receives FDA Approval for Renal Cancer Treatment - Seeking Alpha (blog) |
|
|
Seeking Alpha (blog)... the US Food and Drug Administration's (FDA) approval of Votrient (pazopanib) for the treatment of patients with advanced renal cell carcinoma (RCC), ... read more |